Therapeutic drug monitoring of amikacin in septic patients
Article Quality & Performance Metrics
Readership in this journal
SteadyRanked #3 of 7 articles by views in critical care (london, england)
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
| Reference Key |
w2013criticaltherapeutic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Duszynska W;Taccone FS;Hurkacz M;Kowalska-Krochmal B;Wiela-Hojeńska A;Kübler A;; |
| Journal | critical care (london, england) |
| Year | 2013 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
female
male
aged
middle aged
sepsis / drug therapy*
dose-response relationship
drug
anti-bacterial agents / therapeutic use*
amikacin / therapeutic use*
anti-bacterial agents / blood
pmid:23886243
pmc4057344
doi:10.1186/cc12844
wieslawa duszynska
fabio silvio taccone
andrzej kübler
amikacin / blood
critical illness / therapy*
drug monitoring / methods*
metabolic clearance rate / physiology
sepsis / blood
sepsis / diagnosis
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
ZincirX productsfrom the team behind Journament
-
PatentYazar
Patent drafts for the EPO, USPTO and TürkPatent
From inventor notes to a DOCX draft: description, claims, abstract. The machine drafts, the attorney signs.
See how it works (opens in a new tab) -
Projenator
Have a project idea? Score and plan it with AI
AI scores your idea in five dimensions and builds a phased plan. Your first project is free, no card needed.
Start your first project (opens in a new tab)
Cookies
We use strictly necessary cookies to run the site and keep you signed in. With your permission we would also use Google Analytics to see how the site is used, and Google AdSense to show ads on journal and article pages. Both stay off unless you accept, and you can change your mind at any time. How we use cookies · KVKK notice (Türkiye)
Cookie settings
Comments
No comments yet. Be the first to comment on this article.